Experimental study of antiblastic activity in potentiated antibodies to tumor necrosis factor-alpha.
In mice with Lewis lung carcinoma and melanoma B-16 administration of potentiated antibodies to tumor necrosis factor-alpha started 1 day after transplantation of a small number of tumor cells (10(6)) produced an antiblastic effect.